Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that President and Chief Executive Officer, Dan Schneider will present a corporate overview and host 1-on-1 meetings with investors at the 23rd Annual Needham Healthcare Conference being held virtually April 8-11, 2024.
Presentation Details:
Date: April 11, 2024
Time: 10:15am ET (4:15pm CET)
Webcast Link: https://wsw.com/webcast/needham117/pho.ol/2531984
About the Needham Healthcare Conference
The 23rd Annual Needham Virtual Healthcare Conference will feature leading public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology, and Diagnostics sectors.
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide.
Read More – SOPHiA GENETICS And Strand Life Sciences Announce New Strategic Partnership
Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO).
Read More – Life Fitness And Pavigym Join Forces To Deliver Exceptional Functional And Strength Workouts
